Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

VOR stock hub

Vor Biopharma Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

VORis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

917.9M

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

VOR

In the news

Latest news · VOR

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROEn/a

P25 -105.6P50 -46.5P75 -3.1

ROICn/a

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All VOR market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

179

Groups with data

Currency

USD

Showing 179 of 179 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001817229
Company name	Vor Biopharma Inc.
Country	United States
Country code	US
Cusip	929033207
Employees	76
Employees Change	-83%
Employees Change Percent	-52.2
Enterprise value	$465.7M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
IPO Date	2021-02-05
Isin	US9290332074
Last refreshed	2026-05-10
Market cap	$917.9M
Market cap category	Small-Cap
Price	$16.94
Price currency	USD
Sector	Healthcare
Sic	2836
Symbol	VOR
Website	https://www.vorbio.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-75.82%
FCF yield	-15.65%

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Net Income	$-696M
Net Income Growth Quarters	1%
Net Income Growth Years	0%
Profit Per Employee	$-9.2M
ROA	-70.41
Roa5y	-39.03
ROCE	-77.9

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	58.22%
Cagr3y	-40.04%
Cagr5y	-49%
EPS Growth Quarters	1
EPS Growth Years	0
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	$464.1M
Cash	$455.2M
Current Assets	$458.1M
Current Liabilities	$25.2M
Debt	$3M
Equity	$-164.3M
Liabilities	$628.4M
Long Term Assets	$6M
Long Term Liabilities	$603.3M
Net Cash	$452.2M
Net Cash By Market Cap	$49.27
Net Cash Growth	652.48%
Tangible Book Value	$-164.3M
Tangible Book Value Per Share	$-4.24
WACC	13.84

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	18.2
Net Working Capital	$-22M
Quick ratio	18.08
Working Capital	$432.9M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-187.35%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	58.17%
200-day SMA	21.75
3Y total return	-78.45%
50-day SMA	14.96
50-day SMA vs 200-day SMA	50under200
5Y total return	-96.55%
All Time High	1,272.4
All Time High Change	-98.67%
All Time High Date	2021-02-05
All Time Low	2.62
All Time Low Change	546.07%
All Time Low Date	2025-05-09
ATR	1.08
Beta	1.75
Beta1y	8.85
Beta2y	4.58
Ch YTD	29.51
High	17.32
High52	65.8
High52 Date	2025-07-08
High52ch	-74.26%
Low	15.91
Low52	2.62
Low52 Date	2025-05-09
Low52ch	546.07%
Ma50ch	13.26%
Premarket Change Percent	-0.12
Premarket Price	$16.06
Premarket Volume	2,957
Price vs 200-day SMA	-22.1%
RSI	61.64
RSI Monthly	36.66
RSI Weekly	51.31
Sharpe ratio	1.21x
Sortino ratio	2.12
Total Return	-187.35%
Tr YTD	29.51
Tr1m	0.53%
Tr1w	22.31%
Tr3m	28.72%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	10
Analyst Count Top	6
Analyst Price Target Top	$44
Analyst Ratings	Buy
Analyst Ratings Top	Buy
Earnings EPS Estimate	$-0.78
Operating Income	$-341.9M
Price target	$45.33
Price Target Change	$168
Price Target Change Top	$160

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	43,710,604%
Float Percent	80.67%
Shares Insiders	2.19%
Shares Institutions	37.55%
Shares Out	54,185,737
Shares Qo Q	203.75%
Shares Yo Y	187.35%
Short Float	10.77%
Short Ratio	3.38
Short Shares	8.69

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-162.6M
Average Volume	956,505.4x
Bv Per Share	-4.24
CAPEX	$-941,000
Ch1m	0.53
Ch1w	22.31
Ch1y	58.17
Ch3m	28.72
Ch3y	-78.45
Ch5y	-96.55
Ch6m	-9.41
Change	5.35%
Change From Open	6.01
Close	16.08
Days Gap	-0.62
Depreciation Amortization	2,887,000
Dollar Volume	19,876,244.1
Earnings Date	2026-05-11
Earnings Time	amc
EBIT	$-341.9M
EBITDA	$-339M
EPS	$-70.5
F Score	2
FCF	$-143.7M
FCF EV Yield	-30.85x
FCF Per Share	$-2.65
Financing CF	503,807,000
Fiscal Year End	December
Founded	2,015
Investing CF	-48,802,000
Ipr	-5.89
Iprfo	-97.98
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-03-30
Last Report Date	2025-12-31
Last Split Date	2025-09-19
Last Split Type	Reverse
Last10k Filing Date	2026-03-30
Ma150	15.97
Ma150ch	6.1%
Ma20	15.18
Ma20ch	11.63%
Net CF	312,292,000
Next Earnings Date	2026-05-22
Open	15.98
Optionable	Yes
Position In Range	73.05
Post Close	16.94
Postmarket Change Percent	-1.22
Postmarket Price	$16.73
Ppne	3,469,000
Pre Close	16.08
Price Date	2026-05-08
Relative Volume	1.23x
Share Based Comp	18,912,000
Tr6m	-9.41%
Us State	Massachusetts
Volume	1,173,332

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does VOR pay a dividend?

Capital-return profile for this ticker.

Performance

VOR stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns VOR?

Insider, institutional, and short-interest positioning.

Institutional ownership

+37.5%

Float: +80.7% of shares outstanding

Insider ownership

+2.2%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

VOR momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

61.6

Neutral momentum band

Price vs 200-day MA

-22.1%

50/200-day relationship not available

Beta (5Y)

1.75

More volatile than the market

Sharpe ratio

1.21

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About VOR

Hub-level FAQ points readers to the deeper analysis pages.

What is the current VOR stock rating?

Vor Biopharma Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full VOR analysis?

The full report lives at /stocks/VOR/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for VOR?

The latest report frames VOR around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the VOR page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.